Pay with Crypto and get 10% off your order!
Evaluate for the presence of hereditary or acquired factors that may increase the risk for developing venous thrombosis.
1. Adcock DM, Kressin DC, Marlar RA. Effect of 3.2% vs 3.8% sodium citrate concentration on routine coagulation testing. Am J Clin Pathol. 1997 Jan; 107(1):105-110. PubMed 8980376
2. Reneke J, Etzell J, Leslie S, Ng VL, Gottfried EL. Prolonged prothrombin time and activated partial thromboplastin due to underfilled specimen tubes with 109 mmol/L (3.2%) citrate anticoagulant. Am J Clin Pathol. 1998 Jun; 109(6):754-757. PubMed 9620035
3. National Committee for Clinical Laboratory Standardization. Collection, Transport, and Processing of Blood Specimens for Coagulation Testing and General Performance of Coagulation Assays; Approved Guideline. 5th ed. Villanova, Pa: NCCLS; 2008. Document H21-A5:28(5).
4. Gottfried EL, Adachi MM. Prothrombin time and activated partial thromboplastin time can be performed on the first tube. Am J Clin Pathol.1997 Jun; 107(6):681-683. PubMed 9169665
5. McGlasson DL, More L, Best HA, Norris WL, Doe RH, Ray H. Drawing specimens for coagulation testing: Is a second tube necessary? Clin Lab Sci. 1999 May-Jun; 12(3):137-139. PubMed 10539100
Alving BM. The antiphospholipid syndrome: Clinical presentation, diagnosis and patient management. In: Kitchens CS, Alving BM, Kessler CM, eds. Consultative Hemostasis and Thrombosis. Philadelphia, Pa. WB Saunders Co; 2002:181-196.
Schafer Al, Levine MN, Konkle BA, Kearon C. Thrombotic disorder: Diagnosis and treatment. Hematology (Am Soc Hemataol Educ Program). 2003; 520-539. PubMed 14633797
Triplett DA. Thrombophilia. In: McClatachey KD, ed. Clinical Laboratory Medicine. 2nd ed. Philadelphia, Pa. Lippincott Williams and Wilkins; 2002:1033-1049.
